The EDC3 Knockout NCI-H1299 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population derived from the NCI-H1299 human non-small cell lung carcinoma cell line. This population provides a heterogeneous pool of cells carrying targeted disruptions in the EDC3 gene, enabling robust loss-of-function studies. The polyclonal format ensures representation of multiple independent knockout events, thereby minimizing clonal selection artifacts and offering a more physiologically relevant model for investigating EDC3-dependent mechanisms.
The parental NCI-H1299 cell line is a widely used model of lung adenocarcinoma, originally established from a lymph node metastasis. This non-small cell lung cancer cell line retains critical molecular features of the disease and is extensively employed in oncology research to study tumor progression, metastatic potential, and therapeutic responses. Its metastatic origin makes it particularly suitable for examining the interplay between RNA metabolism and cancer cell behavior.
EDC3 functions as a key enhancer of mRNA decapping, acting within the DCP1-DCP2 decapping complex to promote 5??-3?? mRNA decay. As a core component of cytoplasmic processing bodies (P-bodies), EDC3 interacts with decapping factors DCP1A and DCP2, the LSM1-7 complex, the DEAD-box helicase DDX6, and the scaffold protein PATL1. These interactions facilitate cap removal from targeted mRNAs, directing them toward exonucleolytic degradation by XRN1. EDC3 activity is regulated by upstream assembly of the DCP1A-DCP2 and LSM1-7 complexes, positioning it at a central node in the mRNA surveillance and RNA degradation pathways.
In the NCI-H1299 lung adenocarcinoma background, EDC3 knockout provides a powerful system to dissect the role of mRNA decapping in cancer biology. Dysregulation of mRNA decay pathways is increasingly recognized as a contributor to aberrant gene expression in malignancies, and P-body dynamics have been linked to stress responses and tumor progression. Disrupting EDC3 in this metastatic cell line allows investigation of how altered mRNA turnover influences proliferation, invasion, and drug sensitivity. Additionally, given the association of EDC3 with intellectual disability and neurodevelopmental disorders, this model offers opportunities to explore fundamental post-transcriptional control mechanisms that may have broader implications beyond cancer.
These polyclonal knockout cells are ideal for a range of experimental applications, including RNA stability assays using transcriptional inhibition or metabolic labeling, RT-qPCR and RNA-seq for transcriptome-wide decay analysis, and western blotting to confirm EDC3 protein depletion. Immunofluorescence microscopy enables visualization of P-body assembly, while co-immunoprecipitation studies probe decapping complex integrity. Researchers can use this model to identify downstream mRNA targets, explore compensatory pathways in 5??-3?? decay, and screen for modulators of P-body function. For further details or custom requests, please contact Ascent Research.
